GSK intends to sell its remaining stake in Haleon
British drugmaker GSK said on Thursday it plans to sell about 385 million shares, representing its entire shareholding, in spun-off ...
British drugmaker GSK said on Thursday it plans to sell about 385 million shares, representing its entire shareholding, in spun-off ...
Kenvue, a unit of Johnson & Johnson's consumer health business.CFOTO | Future Publishing | Getty ImagesJohnson & Johnson on Monday ...
Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson's consumer-health business, speaks during an interview to celebrate its IPO ...
© 2024 LSD News title="Jegtheme">Jegtheme.